LENZ Therapeutics IncNASDAQ:LENZ
- LAST PRICE15.7200
- TODAY'S CHANGE (%)0.2700 (1.7476%)
- Bid / Lots14.2000/ 5
- Ask / Lots18.3300/ 1
- Open / Previous Close15.3600 / 15.4500
- Day Range
- 52 Week Range
- Volume200,720
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | LENZ |
|---|---|---|
| 09:32 ET | 275 | 15.36 |
| 09:41 ET | 3262 | 15.34 |
| 09:48 ET | 600 | 15.38 |
| 09:54 ET | 120 | 15.35 |
| 09:57 ET | 800 | 15.24 |
| 10:01 ET | 100 | 15.23 |
| 10:10 ET | 100 | 15.175 |
| 10:12 ET | 100 | 15.175 |
| 10:14 ET | 3171 | 15.4101 |
| 10:17 ET | 100 | 15.265 |
| 10:26 ET | 200 | 15.21 |
| 10:28 ET | 700 | 15.31 |
| 10:30 ET | 100 | 15.51 |
| 10:32 ET | 200 | 15.42 |
| 10:37 ET | 500 | 15.4 |
| 10:39 ET | 200 | 15.43 |
| 10:42 ET | 200 | 15.555 |
| 10:48 ET | 100 | 15.28 |
| 11:00 ET | 300 | 15.23 |
| 11:02 ET | 591 | 15.46 |
| 11:24 ET | 200 | 15.36 |
| 11:26 ET | 100 | 15.48 |
| 11:29 ET | 800 | 15.48 |
| 11:33 ET | 100 | 15.37 |
| 11:38 ET | 200 | 15.47 |
| 11:40 ET | 200 | 15.465 |
| 11:45 ET | 3187 | 15.43 |
| 11:47 ET | 24797 | 15.48 |
| 11:49 ET | 300 | 15.61 |
| 11:54 ET | 300 | 15.54 |
| 12:00 ET | 100 | 15.45 |
| 12:02 ET | 100 | 15.43 |
| 12:03 ET | 100 | 15.43 |
| 12:05 ET | 700 | 15.535 |
| 12:09 ET | 13389 | 15.61 |
| 12:12 ET | 100 | 15.515 |
| 12:14 ET | 300 | 15.57 |
| 12:16 ET | 23600 | 15.61 |
| 12:18 ET | 100 | 15.59 |
| 12:20 ET | 100 | 15.585 |
| 12:30 ET | 100 | 15.53 |
| 12:32 ET | 100 | 15.51 |
| 12:36 ET | 100 | 15.52 |
| 12:38 ET | 200 | 15.52 |
| 12:39 ET | 11883 | 15.59 |
| 12:43 ET | 100 | 15.58 |
| 12:50 ET | 100 | 15.58 |
| 12:56 ET | 100 | 15.58 |
| 12:57 ET | 1106 | 15.76 |
| 12:59 ET | 300 | 15.77 |
| 01:01 ET | 4242 | 15.77 |
| 01:10 ET | 400 | 15.735 |
| 01:12 ET | 300 | 15.725 |
| 01:17 ET | 546 | 15.715 |
| 01:19 ET | 800 | 15.75 |
| 01:21 ET | 4200 | 15.69 |
| 01:32 ET | 200 | 15.61 |
| 01:35 ET | 300 | 15.62 |
| 01:39 ET | 100 | 15.61 |
| 01:44 ET | 100 | 15.61 |
| 01:48 ET | 500 | 15.82 |
| 01:50 ET | 100 | 15.82 |
| 01:51 ET | 100 | 15.85 |
| 01:53 ET | 300 | 15.82 |
| 01:57 ET | 100 | 15.88 |
| 02:00 ET | 100 | 15.76 |
| 02:02 ET | 700 | 15.875 |
| 02:04 ET | 200 | 15.89 |
| 02:06 ET | 875 | 15.77 |
| 02:08 ET | 200 | 15.78 |
| 02:11 ET | 200 | 15.74 |
| 02:13 ET | 100 | 15.76 |
| 02:15 ET | 500 | 15.83 |
| 02:18 ET | 27800 | 15.825 |
| 02:20 ET | 400 | 15.78 |
| 02:22 ET | 300 | 15.87 |
| 02:27 ET | 100 | 15.94 |
| 02:29 ET | 200 | 15.97 |
| 02:33 ET | 4153 | 15.74 |
| 02:36 ET | 200 | 15.92 |
| 02:40 ET | 200 | 15.875 |
| 02:44 ET | 600 | 15.87 |
| 02:47 ET | 400 | 16 |
| 02:49 ET | 400 | 15.98 |
| 02:54 ET | 100 | 15.88 |
| 02:56 ET | 2729 | 15.98 |
| 02:58 ET | 100 | 15.91 |
| 03:02 ET | 1898 | 15.97 |
| 03:03 ET | 800 | 15.99 |
| 03:05 ET | 862 | 15.96 |
| 03:09 ET | 200 | 15.8 |
| 03:12 ET | 100 | 15.8 |
| 03:16 ET | 100 | 15.96 |
| 03:23 ET | 703 | 15.9 |
| 03:27 ET | 100 | 15.8 |
| 03:30 ET | 100 | 15.845 |
| 03:34 ET | 400 | 15.875 |
| 03:39 ET | 100 | 15.84 |
| 03:43 ET | 300 | 15.78 |
| 03:45 ET | 100 | 15.79 |
| 03:48 ET | 200 | 15.79 |
| 03:50 ET | 405 | 15.71 |
| 03:54 ET | 100 | 15.66 |
| 03:57 ET | 1647 | 15.73 |
| 03:59 ET | 5649 | 15.72 |
Apr 15, 2024
DJ LENZ Therapeutics Initiated at Outperform by Leerink Partners, from 10:38AM ET on Monday Apr 15, 2024 by Dow Jones
10:38AM ET on Monday Apr 15, 2024 by Dow JonesDJ LENZ Therapeutics Initiated at Outperform by William Blair, from 8:20AM ET on Monday Apr 15, 2024 by Dow Jones
8:20AM ET on Monday Apr 15, 2024 by Dow Jones
Apr 10, 2024
DJ LENZ Therapeutics Initiated at Buy by Citigroup, from 12:56PM ET on Wednesday Apr 10, 2024 by Dow Jones
12:56PM ET on Wednesday Apr 10, 2024 by Dow Jones
Apr 3, 2024
DJ LENZ Therapeutics Stock Gains 16% After Positive Vision-Loss Trial Data, from 8:55AM ET on Wednesday Apr 03, 2024 by Dow Jones
8:55AM ET on Wednesday Apr 03, 2024 by Dow JonesLENZ Therapeutics Announces Positive Topline Data from Phase 3 CLARITY Presbyopia Trials, from 7:00AM ET on Wednesday Apr 03, 2024 by Dow Jones
7:00AM ET on Wednesday Apr 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
LENZ Therapeutics Inc | 401.4M | -1.0x | --- |
Tourmaline Bio Inc | 402.1M | -1.5x | --- |
Replimune Group Inc | 394.1M | -2.0x | --- |
Larimar Therapeutics Inc | 410.9M | -7.7x | --- |
Lexeo Therapeutics Inc | 411.8M | -4.6x | --- |
Biomea Fusion Inc | 386.9M | -3.1x | --- |
Company Information
LENZ Therapeutics, Inc. is a late clinical-stage biopharmaceutical company. The Company is focused on developing the first aceclidine-based eye drop to improve vision in patients diagnosed with presbyopia. Its product candidates, LNZ100 and LNZ101, are preservative-free, single-use, once-daily eye drops containing aceclidine and aceclidine plus brimonidine, respectively. LNZ100 and LNZ101 are under clinical evaluation in the registration-enabling Phase III CLARITY trials as potential therapies for the treatment of presbyopia, a condition impacting an estimated 1.8 billion people globally and 128 million people in the United States.
Contact Information
- Headquarters
- 445 Marine View Ave Suite 320DEL MAR, CA, United States 92014
- Phone
- 858-925-7000
- Fax
- 302-658-3989
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $401.4M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 25.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-15.35 |
Book Value | $22.15 |
P/E Ratio | -1.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
